Total Funding
78
56
Total FundingSeries B raised
Growth Score 78 in past quarter
-9 pts
Heat Score 56 in past quarter
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
26360
Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.
- Jeremiah Hanes: Senior Vice President of Research & Development
- Jason Gammack: Chief Executive OfficerPast Role: Resolve BioSciences, Co-Founder and Chief Executive Officer
About the Company
Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerate
innovation in biological research and engineering.